U.S. Oil and Gas Stock News

Kiniksa Pharmaceuticals International (KNSA) closed FY 2025 with Q4 revenue of US$202.1 million and basic EPS of US$0.19, alongside net income of US$14.2 million. On a trailing twelve month basis, revenue was US$677.6 million with basic EPS of US$0.80 and net income of US$59.0 million. The company’s quarterly revenue moved from US$122.5 million and a basic EPS loss of US$0.12 in Q4 2024 to US$202.1 million and basic EPS of US$0.19 in Q4 2025. Over the same period, trailing twelve month net...

What Avidity Biosciences’ Recent Returns Signal for Investors Avidity Biosciences (RNA) has drawn attention after a 1 day return close to flat, modest moves over the past week and month, and a very large total return over the past year. For investors, those figures sit alongside a revenue base of US$18.755 million and a reported net loss of US$684.631 million. This highlights that the company remains firmly in a development focused phase. See our latest analysis for Avidity Biosciences. With...

Day One Biopharmaceuticals (DAWN) just reported its FY 2025 numbers, with Q4 total revenue of US$53.7 million and a net loss of US$21.3 million, setting the tone for how investors will read the year as a whole. The company has seen quarterly revenue move from US$29.2 million in Q4 2024 to US$53.7 million in Q4 2025, while Basic EPS shifted from a loss of US$0.64 per share in Q4 2024 to a loss of US$0.19 per share in Q3 2025, giving investors a clear view of how top line scale and loss levels...

Setting the scene on ACV Auctions ACV Auctions (ACVA) has drawn investor attention after a prolonged share price slump, with the stock showing negative returns over the past month, past 3 months, and year to date. At a last close of US$4.51, the wholesale digital auction platform sits against a backdrop of reported annual revenue of US$759.6 million and a net loss of US$66.1 million. This raises questions about how the business fundamentals compare with recent market sentiment. See our latest...

Universal Insurance Holdings FY 2025 Earnings Snapshot Universal Insurance Holdings (UVE) has wrapped up FY 2025 with fourth quarter total revenue of US$407.9 million and basic EPS of US$2.40, alongside net income of US$66.6 million as investors weigh these results against a year where net profit margin moved from 3.9% to 11.4% and earnings growth was very large at about 210.5% year over year. Over recent periods the company has seen total revenue shift from US$384.8 million and basic EPS of...

CeriBell (CBLL) has just closed out FY 2025 with Q4 revenue of US$24.8 million and a basic EPS loss of US$0.36, while trailing 12 month revenue reached US$89.1 million and basic EPS over that period sat at a loss of US$1.46. The company has seen quarterly revenue move from US$18.5 million in Q4 2024 to US$24.8 million in Q4 2025, with basic EPS losses over those quarters ranging between US$0.36 and US$0.40, and trailing 12 month net income remaining in loss territory at US$53.4 million for...

Ironwood Pharmaceuticals (IRWD) just closed out FY 2025 with a mixed Q4 print, reporting revenue of US$47.7 million and a small net loss of US$2.3 million, which translated into EPS of US$0.15 for the trailing twelve months. The company has seen revenue move from US$351.4 million on a trailing basis in Q4 2024 to US$296.2 million in Q4 2025, while trailing EPS shifted from roughly flat at US$0.01 to US$0.15. This sets up a picture in which margins have recently firmed even as top line...

Supernus Pharmaceuticals FY 2025 Earnings Snapshot Supernus Pharmaceuticals (SUPN) has wrapped up FY 2025 with fourth quarter revenue of US$211.6 million, Basic EPS of a US$0.07 loss, and net income excluding extra items showing a US$4.1 million loss. The company reported an increase in revenue from US$174.2 million in Q4 2024 to US$211.6 million in Q4 2025, while Basic EPS moved from US$0.28 in Q4 2024 to a US$0.07 loss in Q4 2025. This combination highlights an expanding top line alongside...

Latest FY 2025 Results Set the Stage for Aspen Aerogels Aspen Aerogels (ASPN) has just wrapped up FY 2025 with Q4 revenue of about US$41.3 million and a basic EPS loss of US$0.88, capping a year in which trailing twelve month revenue came in at roughly US$271.1 million and EPS on the same basis was a loss of US$4.73. Over recent quarters the company has seen quarterly revenue shift from US$123.1 million in Q4 2024 to US$78.7 million in Q1 2025, US$78.0 million in Q2, US$73.0 million in Q3 and...

Euroseas (NasdaqCM:ESEA) has wrapped up FY 2025 with fourth quarter revenue of US$57.4 million and basic EPS of US$5.82, setting the tone for a year where trailing 12 month revenue reached US$227.9 million and EPS came in at US$19.73. Over recent periods, the company has seen quarterly revenue move from US$53.3 million in Q4 2024 to around US$56.3 million to US$57.4 million across 2025. Quarterly EPS shifted from US$3.51 in Q4 2024 to a range of US$4.27 to US$5.82 in 2025, with these earnings...

Beam Therapeutics (BEAM) just posted its FY 2025 numbers with Q4 revenue of US$114.1 million and basic EPS of US$2.37, alongside trailing 12 month revenue of US$139.7 million and a basic EPS loss of US$0.81. Over the past six quarters, the company has seen quarterly revenue range from US$7.5 million to US$114.1 million, while basic EPS has swung from a loss of US$1.24 per share to a gain of US$2.37 per share, reflecting a wide earnings range around its R&D heavy model. For investors, the...

Icahn Enterprises (IEP) just closed out FY 2025 with Q4 revenue of US$2.7b and basic EPS of US$0.00, while trailing twelve month figures show revenue of US$9.7b and a basic EPS loss of US$0.52. Over recent quarters, the company has seen revenue move from US$2.6b in Q4 2024 to US$1.9b in Q1 2025 and then back to US$2.7b in Q4 2025, alongside basic EPS swinging from a loss of US$0.79 in Q1 2025 to a small profit in Q4. This leaves investors weighing how much of this EPS recovery reflects...

Sila Realty Trust (SILA) just reported Q4 FY 2025 results with total revenue of US$50.7 million and basic EPS of US$0.09, alongside funds from operations of US$29.8 million, which is a key metric for REIT investors. The company has seen revenue move from US$46.5 million in Q4 FY 2024 to US$50.7 million in Q4 FY 2025, while trailing 12 month basic EPS stands at US$0.60 and trailing net income is US$33.1 million. Investors will be weighing these figures against expectations for future growth...

Q2 2026 earnings snapshot Manchester United (MANU) has just posted Q2 2026 results with revenue of £190.3 million and basic EPS of £0.024, alongside net income of £4.2 million, putting a profit quarter next to a still loss-making trailing twelve month profile. The club has seen quarterly revenue move between £143.1 million and £198.7 million over the past six reported periods, while basic EPS has ranged from a loss of £0.163 to a profit of £0.024, giving investors a mixed read on headline...

If you are wondering whether Chemours is offering good value at its current price, or if the recent moves are signaling something else about the stock, this article focuses squarely on what the numbers say about value. Chemours' share price closed at US$18.02, with returns of 14.1% over the last 30 days, 47.1% year to date and 16.9% over the past year, while the 7-day return of a 14.8% decline and longer term 3-year and 5-year returns of 42.4% and a 16.4% decline show a mixed picture for...

Evolent Health FY 2025 earnings snapshot Evolent Health (EVH) closed FY 2025 with fourth quarter revenue of US$468.7 million and a basic EPS loss of US$3.84, as the company continued to report negative net income. Over recent periods, revenue has ranged from US$444.3 million to US$483.6 million per quarter, while quarterly basic EPS has stayed in loss-making territory between US$0.24 and US$3.84. This gives investors a clear view of the trade off between top line scale and ongoing earnings...

First Citizens BancShares (FCNCA) has wrapped up FY 2025 with Q4 total revenue of US$2.4b and basic EPS of US$45.78, alongside net income of US$566m that feeds into a trailing 12 month net profit margin of 23.8%, compared with 29.1% a year earlier. Over recent periods, the bank has seen total revenue move between US$2.1b and US$2.4b per quarter and quarterly EPS range from US$34.47 to US$49.18. This gives investors a clear set of numbers to weigh against a five year earnings growth rate of...

Tigo Energy (NasdaqCM:TYGO) closed out FY 2025 with Q4 revenue of US$30.0 million and basic EPS of US$0.17, alongside trailing twelve month revenue of US$103.5 million and a basic EPS loss of US$0.03. The company has seen quarterly revenue move from US$14.2 million in Q3 2024 to US$30.0 million in Q4 2025, while basic EPS shifted from a loss of US$0.22 to a profit of US$0.17 over the same span, setting up a results season in which investors will be weighing improving earnings against a still...

Innoviz Technologies (INVZ) just posted its FY 2025 numbers, with Q4 revenue at US$12.7 million and a basic EPS loss of US$0.10, alongside a trailing twelve month revenue base of US$55.1 million and a full year EPS loss of US$0.34. Over the past two reported years, the company has seen quarterly revenue range from US$4.5 million to US$17.4 million and basic EPS losses between US$0.07 and US$0.15. This gives investors a clearer view of how the top line and per share results have been tracking...

Capri Holdings (NYSE:CPRI) has appointed Tyler Reddien as its new Chief Financial Officer and Chief Operating Officer. Reddien steps into the dual role as the company pursues its plans in the global luxury fashion market. Capri Holdings, the owner of luxury brands in the global fashion and accessories space, now has a single executive overseeing both its finance and operations functions. For investors, a combined CFO and COO role can concentrate responsibility for capital allocation, cost...

Starwood Property Trust (STWD) just wrapped up FY 2025 with fourth quarter revenue of US$148.8 million and basic EPS of US$0.26, alongside trailing twelve month revenue of US$547.9 million and EPS of US$1.15 that reflects reported earnings growth of 16.7% over the past year. Over recent quarters, revenue has ranged from US$125.7 million to US$148.8 million with basic EPS between US$0.19 and US$0.38, while trailing twelve month revenue has moved between US$359.6 million and US$547.9 million as...

SPX Technologies (SPXC) has wrapped up FY 2025 with fourth quarter revenue of US$637.3 million and basic EPS of US$1.57, while trailing twelve month revenue came in at about US$2.3 billion alongside EPS of US$5.13. Over the past few quarters the company has seen revenue move from US$533.7 million in Q4 2024 to US$637.3 million in Q4 2025, with basic EPS stepping from US$1.22 to US$1.57 over the same period. Those results sit on top of trailing earnings growth of 21.7% and a net margin of...

Fidelity National Information Services (FIS) just closed out FY 2025 with Q4 revenue of US$2.8 billion and basic EPS of US$0.99, alongside net income of US$511 million that puts a clear spotlight on how the business is earning each dollar. The company has seen quarterly revenue move from US$2.6 billion and EPS of US$0.15 in Q1 2025 to US$2.8 billion and EPS of US$0.99 in Q4, with trailing twelve month EPS of US$0.73 on revenue of US$10.7 billion framing the broader trend. For investors, the...

Cytokinetics (CYTK) has capped FY 2025 with Q4 revenue of US$17.8 million and a basic EPS loss of US$1.52, anchored by a net loss of US$183.0 million. This sets the tone for how investors are reading the latest update against a year of heavy spending. Over recent periods, the company has seen quarterly revenue range from US$1.6 million to US$66.8 million in FY 2025, while basic EPS losses have moved between US$1.12 and US$2.55. This gives a clear picture of a business that is still investing...